F.Hoffmann-La Roche, Ltd. ,   Switzerland

Antineoplastic agent, monoclonal antibodies

Concentrate for the preparation of a solution for infusions of 100 mg / 4 ml and 400 mg / 16 ml.

Antimicrobial combination

Tablets coated with a coating, 960 mg.

Antineoplastic agent, monoclonal antibodies
Perieta® (pertuzumab), a concentrate for the preparation of a solution for infusions 420 mg / 14 ml; Herceptin® (trastuzumab), lyophilizate for the preparation of concentrate for the preparation of a solution for infusion 440 mg (vials).
Bone resorption inhibitor-bisphosphonate

Tablets, film-coated, 150 mg

Bone resorption inhibitor-bisphosphonate

Tablets, film-coated, 50 mg.

Antitumor agent
Capsules 10 mg.
Antineoplastic agent - monoclonal antibodies.
Solution for subcutaneous administration 600 mg / 5 ml.
Antineoplastic agent - monoclonal antibodies.
Liofilizate for the preparation of concentrate for the preparation of a solution for infusions 440 mg.
Antineoplastic agent - monoclonal antibodies.
Liofilizate for the preparation of a solution for infusions 150 mg
antitumor agent
Tablécoated with film, 240 mg.
Immunosuppressive remedy

Concentrate for the preparation of solution for infusion.

An antiviral [HIV] agent.
Tablets coated with a coating, 500 mg

Antineoplastic agent - monoclonal antibodies.
Liofilizate for the preparation of concentrate for the preparation of a solution for infusions of 100 mg and 160 mg.
Antiemetic means - serotonin receptor antagonist

Tablets, film-coated, 1 mg.

Antiemetic means - serotonin receptor antagonist
Concentrate for solution for infusion, 1 mg / ml.
antitumor agent - protein tyrosine kinase inhibitor

Tablets, film-coated, 20 mg.

GI lipase inhibitor
Capsules 120 mg
Anti-malarial drug

Tablets, 250 mg.

Antitumor and immunomodulating agent - antibodies monoclonal.
A solution for subcutaneous administration of 1400 mg / 11.7 ml

Antitumor and immunomodulating agent - antibodies monoclonal.
Concentrate for the preparation of a solution for infusions of 100 mg / 10 ml and 500 mg / 50 ml.

An antiparkinsonian agent (dopamine precursor + decarboxylase peripheral inhibitor).
Capsules 100 mg + 25 mg

An antiparkinsonian agent (dopamine precursor + decarboxylase peripheral inhibitor).
Dispersible tablets 100 mg + 25 mg, capsules 100 mg + 25 mg, tablets 200 mg + 50 mg, modified-release capsules (capsules GSS) 100 mg + 25 mg.
An antiparkinsonian agent (dopamine precursor + decarboxylase peripheral inhibitor).
Tablets are dispersible 100 mg + 25 mg. capsules 100 mg + 25 mg, tablets 200 mg + 50 mg,capsules with modified release (capsules GSS) 100 mg + 25 mg.
An antiparkinsonian agent (dopamine precursor + decarboxylase peripheral inhibitor).
Capsules with modified release (capsules GSS) 100 mg + 25 mg.
Tablets are dispersible 100 mg + 25 mg. Capsules 100 mg + 25 mg, tablets 200 mg + 50 mg.
Other anti-anemic drugs
Solution for subcutaneous and intravenous administration
Other anti-anemic drugs
Solution for subcutaneous and intravenous administration.
leukopoiesis stimulant
A solution for subcutaneous administration, 30 million units / 0.5 ml, 48 million units / 0.5 ml.
leukopoiesis stimulant

Solution for intravenous and subcutaneous administration, 30 million units / ml.

ejkopoeza stimulant

Solution for subcutaneous administration, 6 mg / 0.6 ml.

cytokine

Solution for subcutaneous administration, 135 μg / 0.5 ml and 180 μg / 0.5 ml.

mucolytic agent

Solution for inhalation, 2.5 mg / 2.5 ml.

hematopoiesis stimulant

Syringe tubes 1000 IU / 0.3 ml. 2000 IU / 0.3 mL, 10,000 IU / 0.6 mL, 20,000 IU / 0.6 mL. 30000 IU / 0.6 ml

hematopoiesis stimulant

Syringe tubes 1000 IU / 0.3 ml. 2000 IU / 0.3 ml. 10,000 IU / 0.6 ml. 20000 IU / 0.6 ml. 30000 IU / 0.6 ml

A remedy for acne.
Capsules 10 mg and 20 mg.
MIBP (medical immunobiological preparations) is an antiviral and antitumor agent.
Solution for subcutaneous administration 3 million IU / 0.5 ml, 4.5 million IU / 0.5 ml, 6 million IU / 0.5 ml, 9 million IU / 0.5 ml.
Antibiotic-cephalosporin
Powder for solution for intramuscular injection 250 mg, 500 mg, 1 g.
Antibiotic-cephalosporin

Powder for the preparation of a solution for intravenous administration of 250 mg, 500 mg, 1 g.

Antibiotic-cephalosporin
Powder for solution for intravenous and intramuscular injection 1 g.

Antibiotic-cephalosporin
Powder for solution for infusion 2 g.

Antiviral agent

Capsules 30 mg and 45 mg.

Antiviral agent

Capsules 75 mg

Antiviral agent
Powder for the preparation of suspension for reception inwards 12 mg / 1 ml
antitumor agent - protein tyrosine kinase inhibitor

Film coated tablets, 25 mg, 100 mg and 150 mg.

Anti-malarial means.

Tablets 500 mg / 25 mg.

antiviral [HIV] agent
Lyophilizate for the preparation of a solution for subcutaneous administration of 90 mg / ml
Antiviral agent

Lyophilizate for solution for infusion, 500 mg.

Immunosuppressive remedy

Capsules, 267 mg.